| 000 | 01875 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517215147.0 | ||
| 264 | 0 | _c20190920 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1946-6242 | ||
| 024 | 7 |
_a10.1126/scitranslmed.aao6459 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlawieh, Ali | |
| 245 | 0 | 0 |
_aTargeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice. _h[electronic resource] |
| 260 |
_bScience translational medicine _c05 2018 |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain Ischemia _xcomplications |
| 650 | 0 | 4 | _aComplement Activation |
| 650 | 0 | 4 |
_aComplement System Proteins _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 |
_aImmunoglobulin M _xmetabolism |
| 650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xcomplications |
| 650 | 0 | 4 |
_aInflammation _xcomplications |
| 650 | 0 | 4 |
_aIschemia _xpathology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMicroglia _xmetabolism |
| 650 | 0 | 4 |
_aNerve Degeneration _xcomplications |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aOpsonin Proteins _xmetabolism |
| 650 | 0 | 4 |
_aPhagocytosis _xdrug effects |
| 650 | 0 | 4 |
_aPneumonia _xcomplications |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xmetabolism |
| 650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
| 650 | 0 | 4 |
_aStroke _xcomplications |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLangley, E Farris | |
| 700 | 1 | _aTomlinson, Stephen | |
| 773 | 0 |
_tScience translational medicine _gvol. 10 _gno. 441 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/scitranslmed.aao6459 _zAvailable from publisher's website |
| 999 |
_c28399040 _d28399040 |
||